Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

J.R. Hecht, S.S. Raman, A. Chan, K. Kalinsky, J.-F. Baurain, M.M. Jimenez, M.M. Garcia, M.D. Berger, U.M. Lauer, A. Khattak, A. Carrato, Y. Zhang, K. Liu, E. Cha, A. Keegan, S. Bhatta, C.P. Strassburg, A. Roohullah

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry